| Property | Value |
|---|
|
?:abstract
|
-
Introduction: There is debate regarding a child’s ability to transmit SARS-CoV-2 to others There is no evidence-based guideline regarding the management of children with persistently positive SARS-CoV-2 PCR testing following recovery from clinical illness Case Description: A 9-year-old Hispanic male with mild persistent asthma on low dose fluticasone and montelukast developed cough and headache Two days later a nasopharyngeal PCR test was positive for SARS-CoV-2 He recovered uneventfully at home Two months later he was scheduled for routine follow-up of his asthma with spirometry As part of institutional protocol, he had repeat SARS-CoV-2 nasopharyngeal PCR and serology testing, both of which were positive He reported no symptoms of COVID-19 As a result of his positive PCR test, his appointments were canceled Discussion: A recent study suggested that children are at low risk of transmitting the SARS-CoV-2 virus This determination was made largely through contact tracing that determined that children were rarely the index case when multiple family members were infected Despite this, a German study demonstrated that viral loads from nasopharyngeal swabs are as high in children as they are in adults We presented the case of a child who had a mild case of COVID-19 and recovered but had persistent PCR positivity despite being asymptomatic The clinical significance of this is unclear More investigation is needed to determine the risk of spread from the pediatric population Elucidating this could allow children easier access to follow-up medical care and the ability to return to school following illness
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Annals_of_Allergy,_Asthma_and_Immunology
-
Annals_of_Allergy_Asthma_&_Immunology
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:source
|
|
|
?:title
|
-
Persistent Positivity of Sars-cov-2 Nasopharyngeal Pcr Test in a Child with Asthma
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}